Targeting the gut-liver axis in liver disease
The gut-liver axis is widely implicated in the pathogenesis of liver diseases, where it is
increasingly the focus of clinical research. Recent studies trialling an array of therapeutic …
increasingly the focus of clinical research. Recent studies trialling an array of therapeutic …
Alterations of gut microbiome in autoimmune hepatitis
Y Wei, Y Li, LI Yan, C Sun, Q Miao, Q Wang, X Xiao… - Gut, 2020 - gut.bmj.com
Objective The significance of the liver-microbiome axis has been increasingly recognised as
a major modulator of autoimmunity. The aim of this study was to take advantage of a large …
a major modulator of autoimmunity. The aim of this study was to take advantage of a large …
[HTML][HTML] Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis
L Bajer, M Kverka, M Kostovcik, P Macinga… - World journal of …, 2017 - ncbi.nlm.nih.gov
AIM To characterize the gut bacterial microbiota of patients with primary sclerosing
cholangitis (PSC) and ulcerative colitis (UC). METHODS Stool samples were collected and …
cholangitis (PSC) and ulcerative colitis (UC). METHODS Stool samples were collected and …
Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling
KM Schneider, LS Candels, JR Hov, M Myllys… - Nature …, 2021 - nature.com
Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease of unknown
aetiology for which there are no approved therapeutic options. Patients with PSC display …
aetiology for which there are no approved therapeutic options. Patients with PSC display …
gutMDisorder: a comprehensive database for dysbiosis of the gut microbiota in disorders and interventions
L Cheng, C Qi, H Zhuang, T Fu… - Nucleic acids research, 2020 - academic.oup.com
Abstract gutMDisorder (http://bio-annotation. cn/gutMDisorder), a manually curated
database, aims at providing a comprehensive resource of dysbiosis of the gut microbiota in …
database, aims at providing a comprehensive resource of dysbiosis of the gut microbiota in …
Fecal microbiota transplantation in patients with primary sclerosing cholangitis: a pilot clinical trial
JR Allegretti, Z Kassam, M Carrellas… - Official journal of the …, 2019 - journals.lww.com
BACKGROUND: Primary sclerosing cholangitis (PSC) is a cholestatic liver disease with no
effective medical therapies. A perturbation of the gut microbiota has been described in …
effective medical therapies. A perturbation of the gut microbiota has been described in …
[HTML][HTML] The microbiome and autoimmunity: a paradigm from the gut–liver axis
B Li, C Selmi, R Tang, ME Gershwin… - Cellular & molecular …, 2018 - nature.com
Microbial cells significantly outnumber human cells in the body, and the microbial flora at
mucosal sites are shaped by environmental factors and, less intuitively, act on host immune …
mucosal sites are shaped by environmental factors and, less intuitively, act on host immune …
The microbiota and the gut–liver axis in primary sclerosing cholangitis
JR Hov, TH Karlsen - Nature Reviews Gastroenterology & Hepatology, 2023 - nature.com
Primary sclerosing cholangitis (PSC) offers unique opportunities to explore the gut–liver axis
owing to the close association between liver disease and colonic inflammation. It is well …
owing to the close association between liver disease and colonic inflammation. It is well …
Quantitative microbiome profiling disentangles inflammation-and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses
S Vieira-Silva, J Sabino, M Valles-Colomer… - Nature …, 2019 - nature.com
Recent work has highlighted the importance of confounder control in microbiome
association studies,. For instance, multiple pathologies previously linked to gut ecosystem …
association studies,. For instance, multiple pathologies previously linked to gut ecosystem …